Aster DM Healthcare Ltd

Aster DM Healthcare Ltd

₹ 261 -0.02%
30 May - close price
About

Aster DM Healthcare Limited is one of the largest integrated private healthcare service providers operating in GCC (Gulf Cooperation Council) countries and an emerging player in India. With an inherent emphasis on clinical excellence, it is one of the few entities in the world with a strong presence across primary, secondary, tertiary and quaternary healthcare. [1]

Key Points

Network
The Co. is an emerging player in India through its network of 27 hospitals, 120 clinics, 371 pharmacies, 14 labs & 100 patient experience centres as on March 31, 2022. [1]

  • Market Cap 13,042 Cr.
  • Current Price 261
  • High / Low 285 / 168
  • Stock P/E 30.7
  • Book Value 89.0
  • Dividend Yield 0.00 %
  • ROCE 9.09 %
  • ROE 10.1 %
  • Face Value 10.0

Pros

  • Promoter holding has increased by 4.00% over last quarter.
  • Company's median sales growth is 16.4% of last 10 years

Cons

  • Stock is trading at 2.93 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Tax rate seems low
  • Company has a low return on equity of 9.81% over last 3 years.
  • Company might be capitalizing the interest cost
  • Promoters have pledged 98.9% of their holding.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023
2,280 1,761 2,243 2,228 2,391 2,372 2,504 2,650 2,728 2,662 2,816 3,192 3,262
1,876 1,618 1,972 1,900 2,070 2,091 2,162 2,252 2,267 2,370 2,498 2,743 2,757
Operating Profit 404 143 271 328 321 281 343 397 460 292 319 449 506
OPM % 18% 8% 12% 15% 13% 12% 14% 15% 17% 11% 11% 14% 16%
25 8 9 7 30 9 10 12 22 37 18 10 15
Interest 112 80 75 62 77 66 61 67 62 69 77 87 96
Depreciation 171 155 153 157 153 153 156 161 170 175 189 198 219
Profit before tax 146 -85 53 115 122 70 135 181 250 85 71 173 206
Tax % -0% -5% 20% 7% 4% 15% 6% 7% 2% 6% 23% 8% 11%
Net Profit 146 -89 42 107 117 60 128 168 246 80 54 159 183
EPS in Rs 2.62 -1.66 0.66 1.85 2.11 0.89 2.14 2.97 4.53 1.37 0.93 2.79 3.42
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
1,922 2,871 3,876 5,250 5,931 6,721 7,963 8,652 8,608 10,253 11,933
1,660 2,421 3,370 4,805 5,582 6,089 6,886 7,187 7,506 8,720 10,368
Operating Profit 261 451 506 445 349 632 1,077 1,465 1,103 1,533 1,565
OPM % 14% 16% 13% 8% 6% 9% 14% 17% 13% 15% 13%
11 19 23 25 453 177 -155 -158 53 51 79
Interest 45 48 79 189 371 204 205 391 334 307 329
Depreciation 76 111 144 243 322 298 306 586 618 641 780
Profit before tax 151 310 306 38 108 308 410 330 205 637 535
Tax % 4% 9% 11% 78% 10% 8% 10% 5% 13% 6% 11%
Net Profit 149 284 272 8 98 282 367 315 178 601 475
EPS in Rs 7.26 4.69 7.00 0.20 2.52 5.32 6.59 5.54 2.96 10.53 8.51
Dividend Payout % 0% 35% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 20%
5 Years: 12%
3 Years: 11%
TTM: 16%
Compounded Profit Growth
10 Years: 16%
5 Years: 22%
3 Years: -1%
TTM: -19%
Stock Price CAGR
10 Years: %
5 Years: 8%
3 Years: 43%
1 Year: 31%
Return on Equity
10 Years: 10%
5 Years: 12%
3 Years: 10%
Last Year: 10%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
125 375 389 403 403 505 505 497 497 497 500
Reserves 654 536 1,096 17 1,472 2,327 2,709 2,775 2,875 3,456 3,949
505 886 1,091 3,321 2,758 2,352 2,788 5,605 4,804 4,907 5,700
856 1,097 1,834 2,003 2,171 2,296 2,926 3,528 3,444 3,661 4,733
Total Liabilities 2,140 2,894 4,409 5,743 6,804 7,479 8,928 12,405 11,620 12,521 14,881
872 1,087 2,237 2,507 3,520 3,738 4,289 7,124 6,749 7,009 9,076
CWIP 185 357 197 358 290 402 550 736 934 998 255
Investments 6 7 3 39 32 38 22 34 63 45 80
1,077 1,442 1,972 2,839 2,962 3,302 4,067 4,511 3,874 4,470 5,470
Total Assets 2,140 2,894 4,409 5,743 6,804 7,479 8,928 12,405 11,620 12,521 14,881

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
236 203 361 537 601 1,223 1,569 1,313 1,834
-439 -775 -1,136 -522 -702 -658 -333 -563 -972
203 578 654 46 134 -675 -1,116 -685 -817
Net Cash Flow -1 5 -122 61 33 -110 120 65 45

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 95 86 83 93 79 84 93 100 86 72 71
Inventory Days 84 71 93 92 102 111 110 138 122 129 135
Days Payable 213 176 178 187 151 150 153 303 290 267 309
Cash Conversion Cycle -34 -18 -2 -1 30 45 50 -65 -83 -66 -102
Working Capital Days 82 61 69 68 57 59 57 40 38 40 33
ROCE % 23% 18% 7% 2% 8% 14% 12% 6% 11% 9%

Shareholding Pattern

Numbers in percentages

Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023
37.88 37.88 37.88 37.88 37.88 37.88 37.88 37.88 37.88 37.88 37.88 41.88
10.49 10.54 10.92 10.57 8.69 10.80 10.95 11.03 11.44 11.77 42.49 38.63
8.49 8.55 8.50 8.72 9.64 8.48 8.45 8.64 9.66 8.99 8.93 8.93
42.59 42.48 42.19 42.33 43.30 42.36 42.24 41.99 40.57 40.91 10.25 10.12
0.55 0.55 0.50 0.50 0.49 0.48 0.47 0.46 0.45 0.45 0.44 0.43

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls